NEPROLVA Trademark

Trademark Overview


On Friday, August 16, 2019, a trademark application was filed for NEPROLVA with the United States Patent and Trademark Office. The USPTO has given the NEPROLVA trademark a serial number of 79269988. The federal status of this trademark filing is REGISTERED as of Tuesday, March 10, 2020. This trademark is owned by Novartis AG. The NEPROLVA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-inf...
neprolva

General Information


Serial Number79269988
Word MarkNEPROLVA
Filing DateFriday, August 16, 2019
Status700 - REGISTERED
Status DateTuesday, March 10, 2020
Registration Number6004765
Registration DateTuesday, March 10, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 24, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics; all of the foregoing excluding nutritional supplements
Translation of Words in MarkThe wording "NEPROLVA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 22, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Friday, June 5, 2020NOTIFICATION PROCESSED BY IB
Friday, May 15, 2020NOTIFICATION PROCESSED BY IB
Wednesday, April 22, 2020FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, April 22, 2020FINAL DISPOSITION PROCESSED
Thursday, April 9, 2020GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, March 10, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, December 24, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 24, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 18, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 18, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 4, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 22, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 22, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 15, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 15, 2019ASSIGNED TO EXAMINER
Saturday, October 26, 2019APPLICATION FILING RECEIPT MAILED
Tuesday, October 22, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 21, 2019LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, October 17, 2019SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB